During the past decade, UCSF School of Medicine conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 12 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 9 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCSF School of Medicine" #1 sponsor was "Therapeutic Advances in Childhood Leukemia Consortium" with 12 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials sponsored, "Acacia Pharma Ltd" with 1 trials sponsored, "Actelion" with 1 trials sponsored and "Bio Products Laboratory" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCSF School of Medicine" #1 collaborator was "Autoimmunity Centers of Excellence" with 2 trials as a collaborator, "Novartis" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Ambit Biosciences Corporation" with 1 trials as a collaborator and "Benaroya Research Institute" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "UCSF School of Medicine" are "Lymphoblastic Leukemia, Acute, Childhood" (5 trials), "Acute Lymphoblastic Leukemia" (3 trials), "Myelogenous Leukemia, Acute, Childhood" (3 trials), "Lymphoblastic Lymphoma" (2 trials) and "Systemic Lupus Erythematosus" (2 trials). Many other conditions were trialed in "UCSF School of Medicine" in a lesser frequency.

Most popular intervention types in "UCSF School of Medicine" are "Drug" (25 trials), "Behavioral" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (8 trials), "Methotrexate" (7 trials), "Placebo" (6 trials), "Dexamethasone" (4 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "UCSF School of Medicine" are 32 trials for "All" genders.

Currently, there are NaN active trials in "UCSF School of Medicine". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in UCSF School of Medicine, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in UCSF School of Medicine, 14 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".